Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
Saved in:
| Title: | Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study. |
|---|---|
| Authors: | Ramaekers JG; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@maastrichtuniversity.nl., Reckweg JT; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Mason NL; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Kuypers KPC; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Toennes SW; Goethe University, Institute of Legal Medicine, Frankfurt, Germany., Theunissen EL; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. |
| Source: | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2025 Jun; Vol. 50 (7), pp. 1084-1092. Date of Electronic Publication: 2024 Dec 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
